跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
福达华 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Fludarabine Phosphate for Injection
Approved
化学药品
Fludarabine Phosphate for Injection
GENZYME EUROPE B.V.
🇨🇳 National Medical Products Administration
Approval Date
Jul 13, 2023
Approval ID
8VIaPX9D41J
Company
GENZYME EUROPE B.V.
Type
化学药品
Approval Details
Approval Id
8VIaPX9D41J
Approval Number
国药准字HJ20140464
Generic Name
注射用磷酸氟达拉滨
Generic Name En
Fludarabine Phosphate for Injection
Trade Name
福达华
Drug Type
化学药品
Dosage Form
注射剂
Strength
50mg
Reg Date
2023-07-13
Expired Date
2028-07-12
Company Name
GENZYME EUROPE B.V.
Production Company Name
Baxter Oncology GmbH
Company Detail Path
/organization/genzyme-europe-b-v
Production Company Detail Path
/organization/baxter-oncology-gmbh
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jul 13, 2023
Approval ID
8VIaPX9D41J
Type
化学药品
Back to NMPA Approvals